To #2: community level emerging substance misuse simulation rapid v BPA the scope of this task order is to enhance the existing ABM by refining and calibrating using real-word data from the city of…
Ended Awarded Last action
- Contract number
- 75F40121F19002
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $698,423
Award facts
- Opportunity
-
- 1237449 Solicitation number
- Contract value 100% obligated
- $698,423.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,285 | |
| Supplemental Agreement for work within scope | $99,770 | |
| Original award | $599,939 |
About this award
This federal contract award, valued at $698,423.41, was issued by the Food and Drug Administration (FDA) as a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The scope of this task order is to enhance an existing Agent-Based Model (ABM) by refining and calibrating it using real-world data from the City of Alexandria. The FDA aims to study several conditions related to community-level emerging substance misuse through this simulation. The contract does not have a set-aside designation, and Booz Allen Hamilton Inc. has a history of providing a wide range of services to federal agencies, including the Department of Defense, Department of Veterans Affairs, and Centers for Disease Control and Prevention. Booz Allen Hamilton Inc. is a subsidiary of Booz Allen Hamilton Holding Corporation, which has over 100 years of experience in supporting critical government initiatives across various sectors.
Description
To #2: community level emerging substance misuse simulation rapid v BPA the scope of this task order is to enhance the existing ABM by refining and calibrating using real-word data from the city of alexandria. FDA aims to study several conditions t
Quick answers
Who was awarded contract 75F40121F19002?
75F40121F19002 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on January 27, 2021.
How much is contract 75F40121F19002 worth?
The government has obligated $698,423 on 75F40121F19002.
Is contract 75F40121F19002 an order under another contract?
Yes. 75F40121F19002 is a BPA call under GS35F386DA-75F40120A00037, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19002 competed?
The extent of competition for 75F40121F19002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award